Clinical consequences of defects in B-cell development

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 4, 2010, Pages 778-787

  Vale, Andre M ^a   Schroeder Jr , Harry W ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

B cell development; B cell immune deficiencies; human; review

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; B CELL LINKER PROTEIN; B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE RECEPTOR; BRUTON TYROSINE KINASE; CD19 ANTIGEN; CD20 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN M; L SELECTIN; PHOSPHOLIPASE C GAMMA; POLYSACCHARIDE; PROTEIN; RAG1 PROTEIN; RAG2 PROTEIN; RITUXIMAB; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW; CELL COMMUNICATION; CELL MATURATION; CELL SELECTION; CELL SURVIVAL; CELLULAR IMMUNITY; CLASS SWITCH RECOMBINATION; ECTOPIC TISSUE; GASTROINTESTINAL MUCOSA; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GERMINAL CENTER; HUMAN; HUMORAL IMMUNITY; HYPER IGM SYNDROME; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; LYMPHOID ORGAN; MEMORY CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; REVIEW; SIGNAL TRANSDUCTION; SOMATIC HYPERMUTATION; SPLEEN; T LYMPHOCYTE;

B-LYMPHOCYTES; CELL DIFFERENTIATION; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY;

EID: 77950195424     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2010.02.018     Document Type: Review

References (67)

1. Tavian M., Robin C., Coulombel L., and Peault B. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 15 (2001) 487-495
2. Matthias P., and Rolink A.G. Transcriptional networks in developing and mature B cells. Nat Rev Immunol 5 (2005) 497-508
3. Nagasawa T. Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 6 (2006) 107-116
4. Nunez C., Nishimoto N., Gartland G.L., Billips L.G., Burrows P.D., Kubagawa H., et al. B cells are generated throughout life in humans. J Immunol 156 (1996) 866-872
5. Milne C.D., and Paige C.J. IL-7: a key regulator of B lymphopoiesis. Semin Immunol 18 (2006) 20-30
6. LeBien T.W., and Tedder T.F. B lymphocytes: how they develop and function. Blood 112 (2008) 1570-1580
7. LeBien T.W. Fates of human B-cell precursors. Blood 96 (2000) 9-23
8. Notarangelo L.D., Fischer A., Geha R.S., Casanova J.L., Chapel H., Conley M.E., et al. Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol 124 (2009) 1161-1178
9. Trinh L.A., Ferrini R., Cobb B.S., Weinmann A.S., Hahm K., Ernst P., et al. Down-regulation of TDT transcription in CD4(+)CD8(+) thymocytes by Ikaros proteins in direct competition with an Ets activator. Genes Dev 15 (2001) 1817-1832
10. Sabbattini P., Lundgren M., Georgiou A., Chow C., Warnes G., and Dillon N. Binding of Ikaros to the lambda5 promoter silences transcription through a mechanism that does not require heterochromatin formation. EMBO J 20 (2001) 2812-2822
11. Rothenberg E.V., Telfer J.C., and Anderson M.K. Transcriptional regulation of lymphocyte lineage commitment. Bioessays 21 (1999) 726-742
12. Wang J.H., Avitahl N., Cariappa A., Friedrich C., Ikeda T., Renold A., et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 9 (1998) 543-553
13. Sun J., Matthias G., Mihatsch M.J., Georgopoulos K., and Matthias P. Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice. J Immunol 170 (2003) 1699-1706
14. Loffert D., Ehlich A., Muller W., and Rajewsky K. Surrogate light chain expression is required to establish immunoglobulin heavy chain allelic exclusion during early B cell development. Immunity 4 (1996) 133-144
15. Yel L., Minegishi Y., Coustan-Smith E., Buckley R.H., Trubel H., Pachman L.M., et al. Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med 335 (1996) 1486-1493
16. Minegishi Y., Coustan-Smith E., Wang Y.H., Cooper M.D., Campana D., and Conley M.E. Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187 (1998) 71-77
17. Wang Y., Kanegane H., Sanal O., Tezcan I., Ersoy F., Futatani T., et al. Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia. Am J Med Genet 108 (2002) 333-336
18. Ferrari S., Lougaris V., Caraffi S., Zuntini R., Yang J., Soresina A., et al. Mutations of the Igbeta gene cause agammaglobulinemia in man. J Exp Med 204 (2007) 2047-2051
19. Wardemann H., and Nussenzweig M.C. B-cell self-tolerance in humans. Adv Immunol 95 (2007) 83-110
20. Nemazee D., and Weigert M. Revising B cell receptors. J Exp Med 191 (2000) 1813-1817
21. Coutinho A., Kazatchkine M.D., and Avrameas S. Natural autoantibodies. Curr Opin Immunol 7 (1995) 812-818
22. Bendelac A., Bonneville M., and Kearney J.F. Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol 1 (2001) 177-186
23. Weill J.C., Weller S., and Reynaud C.A. Human marginal zone B cells. Annu Rev Immunol 27 (2009) 267-285
24. Conley M.E., Mathias D., Treadaway J., Minegishi Y., and Rohrer J. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am J Hum Genet 62 (1998) 1034-1043
25. Aoki Y., Isselbacher K.J., and Pillai S. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc Natl Acad Sci U S A 91 (1994) 10606-10609
26. Fu C., Turck C.W., Kurosaki T., and Chan A.C. BLNK: a central linker protein in B cell activation. Immunity 9 (1998) 93-103
27. Ishiai M., Sugawara H., Kurosaki M., and Kurosaki T. Cutting edge: association of phospholipase C-gamma 2 Src homology 2 domains with BLNK is critical for B cell antigen receptor signaling. J Immunol 163 (1999) 1746-1749
28. Rawlings D.J. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin Immunol 91 (1999) 243-253
29. Webb C.F., Yamashita Y., Ayers N., Evetts S., Paulin Y., Conley M.E., et al. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J Immunol 165 (2000) 6956-6965
30. Conley M.E., Dobbs A.K., Farmer D.M., Kilic S., Paris K., Grigoriadou S., et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 27 (2009) 199-227
31. Conley M.E., and Cooper M.D. Genetic basis of abnormal B cell development. Curr Opin Immunol 10 (1998) 399-406
32. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H.M., Pappu R., Campana D., et al. An essential role for BLNK in human B cell development. Science 286 (1999) 1954-1957
33. LeBien T.W., and McCormack R.T. The common acute lymphoblastic leukemia antigen (CD10)-emancipation from a functional enigma. Blood 73 (1989) 625-635
34. Haas K.M., and Tedder T.F. Role of the CD19 and CD21/35 receptor complex in innate immunity, host defense and autoimmunity. Adv Exp Med Biol 560 (2005) 125-139
35. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354 (2006) 1901-1912
36. Popoff I.J., Savage J.A., Blake J., Johnson P., and Deans J.P. The association between CD20 and Src-family tyrosine kinases requires an additional factor. Mol Immunol 35 (1998) 207-214
37. Kuijpers T.W., Bende R.J., Baars P.A., Grummels A., Derks I.A., Dolman K.M., et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J Clin Invest 120 (2010) 214-222
38. Edwards J.C., and Cambridge G. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat Rev Immunol 6 (2006) 394-403
39. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94 (1999) 1840-1847
40. Mackay F., and Browning J.L. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2 (2002) 465-475
41. Castigli E., and Geha R.S. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 117 (2006) 740-747
42. Lopes-Carvalho T., Foote J., and Kearney J.F. Marginal zone B cells in lymphocyte activation and regulation. Curr Opin Immunol 17 (2005) 244-250
43. Carsetti R., Rosado M.M., and Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev 197 (2004) 179-191
44. Jacob J., Kelsoe G., Rajewsky K., and Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature 354 (1991) 389-392
45. Klein U., and Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat Rev Immunol 8 (2008) 22-33
46. MacLennan I.C. Germinal centers. Annu Rev Immunol 12 (1994) 117-139
47. Facchetti F., Appiani C., Salvi L., Levy J., and Notarangelo L.D. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells. J Immunol 154 (1995) 6624-6633
48. Camacho S.A., Kosco-Vilbois M.H., and Berek C. The dynamic structure of the germinal center. Immunol Today 19 (1998) 511-514
49. Berek C., Berger A., and Apel M. Maturation of the immune response in germinal centers. Cell 67 (1991) 1121-1129
50. Schwickert T.A., Lindquist R.L., Shakhar G., Livshits G., Skokos D., Kosco-Vilbois M.H., et al. In vivo imaging of germinal centres reveals a dynamic open structure. Nature 446 (2007) 83-87
51. Wagner S.D., and Neuberger M.S. Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 14 (1996) 441-457
52. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., and Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102 (2000) 553-563
53. Neuberger M.S., Harris R.S., Di Noia J., and Petersen-Mahrt S.K. Immunity through DNA deamination. Trends Biochem Sci 28 (2003) 305-312
54. Honjo T., Muramatsu M., and Fagarasan S. AID: how does it aid antibody diversity?. Immunity 20 (2004) 659-668
55. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102 (2000) 565-575
56. Kuppers R., and Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20 (2001) 5580-5594
57. Manz R.A., Hauser A.E., Hiepe F., and Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 23 (2005) 367-386
58. Durandy A., Revy P., Imai K., and Fischer A. Hyper-immunoglobulin M syndromes caused by intrinsic B-lymphocyte defects. Immunol Rev 203 (2005) 67-79
59. Klein U., Rajewsky K., and Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188 (1998) 1679-1689
60. Fecteau J.F., Cote G., and Neron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 177 (2006) 3728-3736
61. Ehrhardt G.R., Hsu J.T., Gartland L., Leu C.M., Zhang S., Davis R.S., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202 (2005) 783-791
62. Ehrhardt G.R., Hijikata A., Kitamura H., Ohara O., Wang J.Y., and Cooper M.D. Discriminating gene expression profiles of memory B cell subpopulations. J Exp Med 205 (2008) 1807-1817
63. Macpherson A.J., McCoy K.D., Johansen F.E., and Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol 1 (2008) 11-22
64. Fagarasan S., and Honjo T. Regulation of IgA synthesis at mucosal surfaces. Curr Opin Immunol 16 (2004) 277-283
65. Gould H.J., Sutton B.J., Beavil A.J., Beavil R.L., McCloskey N., Coker H.A., et al. The biology of IGE and the basis of allergic disease. Annu Rev Immunol 21 (2003) 579-628
66. Weyand C.M., Klimiuk P.A., and Goronzy J.J. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol 20 (1998) 5-22
67. Kim H.J., and Berek C. B cells in rheumatoid arthritis. Arthritis Res 2 (2000) 126-131